Skip to content

Dr Reddy’s Q2 preview: Pharma major likely to report sharp drop net profit on weak US biz

Dr Reddy’s North American operations will set the tone for the September quarter performance, as likely price erosion will trigger a decline in sales on a year-on-year basis

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish